Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-α treatment

Journal of Psychosomatic Research

Volumn 58, Issue 1, 2005, Pages 15-18

  Beratis, Stavroula ^a   Katrivanou, Aggeliki ^a   Georgiou, Sophia ^a   Monastirli, Alexandra ^a   Pasmatzi, Efstathia ^a   Gourzis, Philippos ^a   Tsambaos, Dionysios ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Antidepressants; Interferon ; Major depressive episode; Risk; Severity of depressive symptomatology

Indexed keywords

ALPHA INTERFERON; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG DOSE REGIMEN; EVALUATION; FEMALE; HAMILTON SCALE; HUMAN; LOW DRUG DOSE; MAJOR DEPRESSION; MALE; RISK ASSESSMENT; SYMPTOMATOLOGY;

EID: 14844355112     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2004.03.010     Document Type: Article

References (19)

1. J Kirkwood Cancer immunotherapy: the interferon-alpha experience Semin Oncol 29 3 Suppl 7 2002 18 26
2. UR Malik, DF Makower, and S Wadler Interferon-mediated fatigue Cancer 92 2001 1664 1668
3. F Adams, F Fernandez, and G Mavligit Interferon induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities J Neurooncol 6 1988 355 359
4. EM McDonald, AH Mann, and HC Thomas Interferons as mediators of psychiatric morbidity: an investigation in a trial of recombinant α-interferon in hepatitis-B carriers Lancet 2 1987 1175 1178
5. H Smedley, M Katrak, K Sikora, and T Wheeler Neurological effects of recombinant human interferon BMJ 286 1983 262 264
6. L Capuron, JF Gumnick, DL Musselman, DH Lawson, A Reemsnyder, CB Nemeroff, and AH Miller Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetin responsiveness of symptom dimentions Neuropsychopharmacology 26 2002 643 652
7. DB Greenberg, E Jonasch, MA Gadd, BF Ryan, JR Everett, AJ Sober, MA Mihm, KK Tanabe, M Ott, and FG Haluska Adjuvant therapy of melanoma with interferon-alpha-2β is associated with mania and bipolar syndromes Cancer 89 2000 356 362
8. L Capuron, A Ravand, and R Dantzer Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-α treatments in cancer patients Psychosom Med 63 2001 766 786
9. L Capuron, CL Raison, DL Musselmann, DH Lawson, CB Nemeroff, and AH Miller Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy Am J Psychiatry 160 2003 1342 1345
10. N Horikawa, T Yamazaki, N Izumi, and M Uchihara Incidence and clinical course of major depression in patients with chronic hepatitis C undergoing interferon-alpha therapy: a prospective study Gen Hosp Psychiatry 25 2003 34 38
11. JP Lang, O Halleguen, C Vecchionacci, and M Doffoel Réflexions sur la prise en charge d'episode depressif majeur (EDM) chez les patients infectés par le virus de l'hepatite C (VHC) traités par interféron alpha à partir d'une etude rétrospective concernant 29 patients Encephale 29 2003 273 277
12. L Capuron, A Ravand, PS Neven, AH Miller, M Mae, and R Dantzer Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy Mol Psychiatry 7 2002 468 473
13. R De La Garza, and GM Asnis The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-α induced alterations to monoamine turnover in prefrontal cortex and hippocampus Brain Res 977 2003 70 79
14. EM Cassidy, D Manning, S Byrne, E Bolger, F Marray, N Sharifi, E Wallace, M Keogan, and V O'Keane Acute effects of low-dose interferon-α on serum cortisol and plasma interlukin-6 J Psychopharmacol 16 2002 230 234
15. S Bonaccorso, A Puzella, V Marino, M Pasquini, M Biondi, M Artini, C Almerighi, M Levrero, B Egyed, E Bosmans, HY Meltzer, and M Maes Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms Psychiatry Res 105 2001 45 55
16. A Scalori, P Apale, F Panizzuti, N Mascoli, P Pioltelli, M Pozzi, A Redealli, L Roffi, and G Manua Depression during interferon therapy for chronic viral hepatitis: early identification of patients at risk by means of a computerized test Eur J Gastrenterol Hepatol 12 2000 505 509
17. RL Spitzer, JBW Williams, M Gibbon, and MB First Structured clinical interview for DSM-III-R, patient edition (SCID-P) 1990 American Psychiatric Press Washington (DC)
18. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed 1994 American Psychiatric Association Washington (DC)
19. M Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62